Cara Therapeutics Inc (CARA)
0.7224
+0.02
(+3.20%)
USD |
NASDAQ |
Apr 26, 14:49
Cara Therapeutics Profit Margin (Quarterly): -1.08K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.08K% |
| September 30, 2023 | -576.1% |
| June 30, 2023 | -454.0% |
| March 31, 2023 | -432.5% |
| December 31, 2022 | -930.4% |
| September 30, 2022 | -214.4% |
| June 30, 2022 | -18.28% |
| March 31, 2022 | -579.3% |
| December 31, 2021 | -4.07K% |
| September 30, 2021 | -5.00% |
| June 30, 2021 | |
| March 31, 2021 | -1.20K% |
| December 31, 2020 | 70.40% |
| September 30, 2020 | -178.2% |
| June 30, 2020 | -444.9% |
| March 31, 2020 | -357.4% |
| December 31, 2019 | -634.2% |
| September 30, 2019 | -567.7% |
| June 30, 2019 | -440.9% |
| March 31, 2019 | -501.1% |
| December 31, 2018 | -373.3% |
| September 30, 2018 | -383.2% |
| Date | Value |
|---|---|
| June 30, 2018 | -598.3% |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | -2.44K% |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | -16.55K% |
| March 31, 2016 | -152.7K% |
| December 31, 2015 | |
| September 30, 2015 | -196.2% |
| June 30, 2015 | -650.3% |
| March 31, 2015 | -958.9% |
| December 31, 2014 | -456.5% |
| September 30, 2014 | -581.8% |
| June 30, 2014 | -379.7% |
| March 31, 2014 | -1.90K% |
| December 31, 2013 | -215.1% |
| September 30, 2013 | -449.4% |
| June 30, 2013 | 53.51% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-4.07K%
Minimum
Dec 2021
70.40%
Maximum
Dec 2020
-672.8%
Average
-449.5%
Median
Profit Margin (Quarterly) Benchmarks
| Nektar Therapeutics | -176.2% |
| Stereotaxis Inc | -110.4% |
| Cerus Corp | -2.84% |
| Avid Bioservices Inc | -17.76% |
| Rigel Pharmaceuticals Inc | 2.06% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -108.3% |
| Return on Assets | -83.33% |
| Return on Invested Capital | -108.3% |
| Gross Profit Margin (Quarterly) | 79.76% |
| Operating Margin (Quarterly) | -1.09K% |
| Return on Net Operating Assets | -427.4% |